Government ❯ Health Policy

Medicare

Regulations Drug Price Negotiation Drug Pricing Medicaid Drug Regulation Funding Drug Coverage Drug Negotiations Drug Negotiation Regulatory Agencies

CMS Halts New Medicare Enrollment for Home Health and Hospice Nationwide

The freeze signals a tougher fraud-prevention stance that could reshape provider growth.

CMS Halts New Medicare Enrollment for Hospices and Home Health Agencies Nationwide

CMS and FDA Launch RAPID Pathway to Speed Medicare Coverage for Breakthrough Devices

CMS Finalizes 2.48% Medicare Advantage Rate Hike for 2027

CMS Finalizes 2027 Medicare Advantage Rule, Overhauling Star Ratings and Part D

CMS Links Hospital Meal Standards to Medicare, Medicaid Eligibility

CMS Puts Six-Month Freeze on New Medicare Enrollment for Many DMEPOS Suppliers

Houston Transplant Surgeon Indicted Over Alleged Record Falsification That Blocked Liver Transplants

Medicare GLP-1 Use Surges as CMS Advances Coverage Expansion and Lilly Eyes Q2 Pill Launch

CMS Sets ACCESS Model Deadlines for July Launch of Outcome-Based Chronic Care

CMS Picks CLEAR to Modernize Medicare.gov Identity Verification Starting in 2026

CMS Chief Mehmet Oz Urges Medicare Enrollees to Act Before Dec. 7 Deadline

Lilly Cuts Zepbound Cash Prices on LillyDirect as GLP‑1 Price Competition Deepens

Experts Question Impact of Trump’s Drug-Price Deals With Pfizer and AstraZeneca

UnitedHealthcare, Humana and Aetna Scale Back 2026 Medicare Advantage Footprints as Enrollment Window Opens

CMS Projects 2026 Medicare Premiums to Fall as Insurers Trim Plans Ahead of Open Enrollment

Weiss Hospital Faces Appeal Deadline as Lawmakers Freeze $4 Million and Community Presses Reopening

Medicare to Test AI-Screened Prior Authorization in Six States Starting in 2026

RFK Jr. and Dr. Oz Promote 15-Minute Outdoor Break in New PSA

U.S. Finalizes 5.06% Medicare Advantage Rate Hike for 2026